These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 832672)

  • 1. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
    Raiteri M; Del Carmine R; Bertollini A; Levi G
    Eur J Pharmacol; 1977 Jan; 41(2):133-43. PubMed ID: 832672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
    Raiteri M; Bertollini A; Angelini F; Levi G
    Eur J Pharmacol; 1975 Nov; 34(1):189-95. PubMed ID: 1234761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of synaptosomal uptake of norepinephrine and dopamine by conformationally restricted sympathomimetic amines.
    Komiskey HL; Hsu FL; Bossart FJ; Fowble JW; Miller DD; Patil PN
    Eur J Pharmacol; 1978 Nov; 52(1):37-45. PubMed ID: 720387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates.
    Horn AS
    Br J Pharmacol; 1973 Feb; 47(2):332-8. PubMed ID: 4722047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional changes in monoamine content and uptake of the rat brain during postnatal development.
    Nomura Y; Naitoh F; Segawa T
    Brain Res; 1976 Jan; 101(2):305-15. PubMed ID: 1244975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo.
    Bonnet JJ; Costentin J
    Eur J Pharmacol; 1986 Feb; 121(2):199-209. PubMed ID: 3754516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
    Wells GB; Lopez MC; Tanaka JC
    Brain Res Bull; 1999 Apr; 48(6):641-7. PubMed ID: 10386845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
    Tseng LF; Menon MK; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.
    McKenna DJ; Guan XM; Shulgin AT
    Pharmacol Biochem Behav; 1991 Mar; 38(3):505-12. PubMed ID: 1829838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
    Johnson MP; Conarty PF; Nichols DE
    Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Para-substituted amphetamines and brain serotonin.
    Magyar K; Knoll J
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):139-43. PubMed ID: 1208223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of xylamine on the uptake of [3H]dopamine into isolated striatal synaptosomes of the rats.
    Liang P; Chang SS; Cheng JT
    Neurosci Lett; 1993 Apr; 153(2):181-4. PubMed ID: 8392155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of phencyclidine on the uptake of 3H-catecholamines by rat striatal and hypothalamic synaptosomes.
    Garey RE; Heath RG
    Life Sci; 1976 May; 18(10):1105-10. PubMed ID: 933700
    [No Abstract]   [Full Text] [Related]  

  • 16. Mepiprazole, a new psychotropic drug: effects on uptake and retention of monoamines in rat brain synaptosomes.
    Placheta P; Singer E; Kriwanek W; Hertting G
    Psychopharmacology (Berl); 1976 Aug; 48(3):295-301. PubMed ID: 9660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of nefopam and its enantiomers on the uptake of 5-hydroxytryptamine, noradrenaline and dopamine in crude rat brain synaptosomal preparations.
    Rosland JH; Hole K
    J Pharm Pharmacol; 1990 Jun; 42(6):437-8. PubMed ID: 1979627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat.
    Blurton PA; Broadhurst AM; Cross JA; Ennis C; Wood MD; Wyllie MG
    Neuropharmacology; 1984 Sep; 23(9):1049-52. PubMed ID: 6514142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phenethylamine derivatives on the release of biogenic amines from synaptosomes.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Biochem Soc Trans; 1976; 4(1):121-4. PubMed ID: 1001613
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.